Wuppertal, Germany

John E Ransohoff


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of John E. Ransohoff in Pharmaceutical Chemistry

Introduction

John E. Ransohoff, an inventive mind hailing from Wuppertal, Germany, has made significant contributions to the field of pharmaceutical chemistry. With a patent portfolio that reflects his innovative approach, Ransohoff’s work primarily focuses on substituted alkenoic acids and their derivatives, showcasing his expertise and dedication to advancing therapeutic solutions.

Latest Patents

Ransohoff holds a patent for "Substituted alkenoic acid and its derivatives." This innovative work outlines a process for preparing new substituted alkenoic acid derivatives by reacting an appropriate aldehyde with a phosphonium compound. Notably, these compounds exhibit leukotriene antagonistic properties, making them promising candidates for incorporation into pharmaceutical compositions that could address various health conditions.

Career Highlights

Ransohoff’s career is closely associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His tenure there emphasizes his commitment to research and development in the pharmaceutical sector. The quality of his work, particularly in the synthesis of novel chemical compounds, has contributed to the company’s ongoing success and innovation.

Collaborations

Throughout his career, John E. Ransohoff has had the opportunity to collaborate with notable scientists, including Heinrich Meier and Trevor S. Abram. These collaborations have allowed for the exchange of ideas and expertise, resulting in advancements that benefit not only the individuals involved but also the broader scientific community.

Conclusion

John E. Ransohoff stands out as a significant figure in the realm of pharmaceutical innovations. His patent on substituted alkenoic acids demonstrates his ability to address complex challenges within the field and reflects his ongoing commitment to improving health outcomes through scientific exploration and collaboration. As pharmaceutical research continues to evolve, Ransohoff’s contributions remain crucial in shaping future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…